This review discusses the history of the classification of soft tissue sarcomas in children and adolescents, the current transition toward integration of morphology and molecular genetics as new entities emerge, and future perspectives.
WeissSW, ed. Histological Typing of Soft Tissue Tumours. World Health Organization International Classification of Tumours, 2nd ed.. Berlin: Springer-Verlag, 1994.
9.
DemiccoEG. Sarcoma diagnosis in the age of molecular pathology. Adv Anat Pathol2013;20:264–274.
10.
LinGDoyleL. An update on the application of newly described immunohistochemical markers in soft tissue pathology. Arch Pathol Lab Med2015;139:106–121.
11.
GuillouLBenhattarJGenglerC. Translocation positive low-grade fibromyxoid sarcoma. Clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: A study from the French Sarcoma Group. Am J Surg Pathol2007;31:1387–1402.
12.
FletcherCDMUnniKKMertensF, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002.
13.
FletcherCDMBridgeJAHogendoornPCWMertensF, eds. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC, 2013.
14.
StoutAP. Rhabdomyosarcoma of the skeletal muscles. Ann Surg1946;123:447–472.
15.
StobbeGDDargeonHW. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer1950;3:826–836.
16.
HornRCYakovacWCKayeRKoopCE. Rhabdomyosarcoma (sarcoma botryoides) of common bile duct: Report of case. Cancer1955;8:468–477.
17.
RiopelleJLTheriaultJP. Sur une forme méconnue de sarcome des parties molles: Le rhabdomyosarcoma alvéolaire. Ann Anat Pathol1956;1:88–111.
18.
HornRCEnterlineHT. Rhabdomyosarcoma: A clinicopathological study and classification of 39 cases. Cancer1958;11:181–199.
19.
EnzingerFMShirakiM. Alveolar rhabdomyosarcoma: An analysis of 110 cases. Cancer1969;24:18–31.
20.
StoutAPLattesR. Tumors of the Soft Tissues. Atlas of Tumor Pathology; 2nd series, fascicle 1. Washington, DC: Armed Forces Institute of Pathology, 1967;134–144.
21.
Gonzalez-CrussiFBlack-SchafferS. Rhabdomyosarcoma of infancy and childhood: Problems of morphological classification. Am J Surg Pathol1979;3:157–171.
22.
BalePMReyeRDK. Rhabdomyosarcoma in childhood. Pathology1975;7:101–111.
23.
CavazzanaAOSchmidtDNinfoV. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol1992;16:229–235.
24.
AsmarLGehanEANewtonWA. Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: Report of an international study of 4 pathology classifications. Cancer1994;74:2579–2588.
25.
NewtonWAGehanEAWebberBL. Classification of rhabdomyosarcoma and related sarcomas: Pathologic aspects and proposal for a new classification—an international rhabdomyosarcoma classification. Cancer1995;76:1073–1085.
26.
CoffinCM. The new international rhabdomyosarcoma classification, its progenitors, and considerations beyond morphology. Adv Anat Pathol1997;4:1–16.
27.
QualmanSJBowenJParhamDM. Protocol for the examination of specimens from patients (children and young adults) with rhabdomyosarcoma. Arch Pathol Lab Med2003;127:1290–1297.
28.
ParhamDMQualmanSJTeotL. Correlation between histology and PAX7FKHR fusion studies in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group. Am J Surg Pathol2007;31:895–901.
29.
MalempatiSHawkinsDS. Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) Soft Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer2012;59:5–10.
30.
DavicioniEAndersonMJFinckensteinFG. Molecular characterization of rhabdomyosarcoma—genotypic and phenotypic determinants of diagnosis: A report from the Children's Oncology Group. Am J Pathol2009;174:550–564.
31.
WilliamsonDMissiagliaEde ReyniesA. Fusion-gene negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol2010;28:2152–2158.
32.
WexlerLHLadanyiM. Diagnosing alveolar rhabdomyosarcoma: Morphology must be coupled with fusion confirmation. J Clin Oncol2010;28:2126–2128.
33.
RudzinskiERAndersonJRHawkinsDSSkapekSXParhamDMTeotLA. The World Health Organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma. A report from the Children's Oncology Group. Arch Pathol Lab Med2015;139:1281–1287.
34.
ParhamDM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol2001;14:506–514.
35.
MissiagliaEWilliamsonDChisholmJ. PAX3/FOX01 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol2012;30:1670–1677.
36.
TsokosMWebberBParhamD. Rhabdomyosarcoma: A new classification scheme related to prognosis. Arch Pathol Lab Med1992;116:847–855.
37.
RudzinskiERTeotLAAndersonJR. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol2013;140:82–90.
38.
FletcherCDM. The evolving classification of soft tissue tumours—an update based on the new 2013 WHO classification. Histopathology2014;64:2–11.
39.
NascimentoAFFletcherCDM. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol2005;29:1106–1113.
40.
FolpeALMcKenneyJKBridgeJA. Sclerosing rhabdomyosarcoma in adults: Report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol2002;26:1175–1183.
41.
MentzelTKuhnenC. Spindle cell rhabdomyosarcoma in adults: Clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch2006;449:554–560.
42.
ChilesMCParhamDMQualmanSJ. Sclerosing rhabdomyosarcomas in children and adolescents: A clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol2004;7:583–594.
43.
SzuhaiKde JongDLeungWYFletcherCDHogendoornPC. Transactivating mutation of the MyoD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. J Pathol2014;232:300–307.
44.
AgaramNChenCLZhangLLaQuagliaMPWexlerLAntonescuC. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis. Genes Chromosomes Cancer2014;53:779–787.
MeyerdingHWBrodersACHargraveRL. Clinical aspects of fibrosarcoma of the soft tissues of the extremities. Surg Gynecol Obstet1936;62:1010–1019.
47.
BrodersACHargraveRMeyerdingHW. Pathological features of fibrosarcoma, with special reference to the grading of its malignancy. Surg Gynecol Obstet1939;69:267–280.
48.
StoutAP. Fibrosarcoma: The malignant tumor of fibroblasts. Cancer1948;1:30–63.
49.
BahramiAFolpeAL. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol2010;34:1504–1513.
50.
FolpeAL. Fibrosarcoma: A review and update. Histopathology2014;64:12–25.
51.
CoffinCMAlaggioR. Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol2012;15(suppl):127–180.
52.
BillingsSDGiblenGFanburg-SmithJC. Superficial low-grade fibromyxoid sarcoma (Evans tumor): A clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol2005;29:204–210.
53.
MertensFFletcherCDAntonescuCR. Clinical and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest2005;85:408–415.
54.
DoyleLAMollerEDal CinP. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol2011;35:733–741.
55.
EvansHL. Low-grade fibromyxoid sarcoma: A clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol2011;35:1450–1462.
56.
Meis-KindblomJMKindblomLGEnzingerFM. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol1995;19:979–993.
57.
AntonescuCRRosenblumMKPereiraPNascimentoAGWoodruffJM. Sclerosing epithelioid fibrosarcoma: A study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol2001;25:699–709.
58.
WangWLEvansHLMeisJM. FUS rearrangements are rare in “pure” sclerosing epithelioid fibrosarcoma. Mod Pathol2012;25:846–853.
59.
DoyleLAWangWLDal CinP. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: Association with FUS gene rearrangement. Am J Surg Pathol2012;36:1444–1451.
60.
CatesJMMCoffinCM. Neurogenic tumors of soft tissue. Pediatr Dev Pathol2012;15(suppl):62–107.
61.
CoffinCMCassityJViskochilD. Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Genet A2004;127:40–43.
62.
FerrariABisognoGMacalusoA. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer2007;109:1406–1412.
63.
DucatmanBSScheithauerBWPiepgrasDG. Malignant peripheral nerve sheath tumors: A clinicopathologic study of 120 cases. Cancer1986;57:2006–2021.
64.
DucatmanBSScheithauerBWPiepgrasDG. Malignant peripheral nerve sheath tumors in childhood. J Neurooncol1984;2:241–248.
65.
RodriguezFJFolpeALGianniniC. Pathology of peripheral nerve sheath tumors: Diagnostic overview and update on selected diagnostic problems. Acta Neuropathol2012;123:295–319.
66.
PecmezkiMReussDEHirbeAC. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Mod Pathol2015;28:187–200.
67.
ZhouHCoffinCMPerkinsSL. Malignant peripheral nerve sheath tumor: A comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol2003;27:1337–1345.
68.
BrekkeHRKolbergMSkotheimRI. Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors. Neuro-oncol2009;11:514–528.
69.
BottiloIAhlquistTBrekkeH. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumors. J Pathol2009;217:693–701.
70.
BoueDRParhamDMWebberB. Clinicopathologic study of ectomesenchymoma from Intergroup Rhabdomyosarcoma Study Groups III and IV. Pediatr Dev Pathol2000;3:290–300.
HowleySStackDMorrisT. Ectomesenchymoma with t(1;12)(p32;p13) evolving from embryonal rhabdomyosarcoma shows no rearrangement of ETV6. Hum Pathol2012;43:299–302.
73.
AndersonDH. Tumors of infancy and childhood. I. A survey of those seen in the pathology laboratory of the Babies' Hospital during the years 1935–1950. Cancer1951;4:890–906.
74.
PackGTArielIM. Sarcomas of the soft somatic tissue in infants and children. Surg Gynecol Obstet1954;98:675–686.
75.
SouleEHMahourGHMillsSDLynnHB. Soft tissue sarcomas of infants and children: A clinicopathologic study of 135 cases. Mayo Clin Proc1968;43:313–326.
76.
AlaggioRBisognoGRosatoA. Undifferentiated sarcoma: Does it exist? A clinicopathologic study of 7 pediatric cases and review of literature. Hum Pathol2009;40:1600–1610.
77.
RaneyRBAndersonJRBarrFG. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol2001;23:215–220.
78.
SalloumEFlamantFCaillaudJM. Diagnostic and therapeutic problems of soft tissue tumors other than rhabdomyosarcoma in infants under 1 year of age: A clinicopathological study of 34 cases treated at the Institut Gustav-Roussy. Med Pediatr Oncol1990;18:37–43.
79.
HarmsD. Soft tissue sarcomas in the Kiel Pediatric Tumor Registry. Curr Top Pathol1995;89:31–45.
80.
PawelBRHamoudiABAsmarL. Undifferentiated sarcomas of children: Pathology and clinical behavior. An intergroup rhabdomyosarcoma study. Med Pediatr Oncol1997;29:170–180.
81.
SpuntSLMillionLAndersonJR. Risk-based treatment for non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in patients under 30 years of age: Children's Oncology Group study ARST0332 (abstract). J Clin Oncol2014;32(5s):10008.
82.
FletcherCD. Undifferentiated sarcomas: What to do? And does it matter? A surgical pathology perspective. Ultrastruct Pathol2008;32:31–36.
83.
AlaggioRColliniPRandallRL. Undifferentiated high-grade pleomorphic sarcomas in children: A clinicopathologic study of 10 cases and review of literature. Pediatr Dev Pathol2010;13:209–217.
84.
SakharpeALahatGGulamhuseinT. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: Clinicopathologic features, molecular markers, and a new experimental model. Oncologist2011;16:512–522.
85.
SadikovicBGrahamCHoMZielenskaMSomersG. Immunohistochemical expression and cluster analysis of mesenchymal and neural stem cell-associated proteins in pediatric soft tissue sarcomas. Pediatr Dev Pathol2011;14:259–272.
86.
YoshimotoMGrahamCChilton-MacNeillS. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet2009;195:1–11.
87.
ItalianoASungYSZhangL. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer2012;51:207–218.
88.
GrahamCChilton-MacNeillSZielenskaMSomersGR. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol2012;43:180–189.
89.
SmithSCBuehlerDChoiEYC. CIC-DUX4 sarcomas demonstrate frequent MYC amplification and ETS family transcription factor expression. Mod Pathol2015;28:57–68.
90.
KreigerPAJudkinsARRussoPA. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol2009;22:142–150.
91.
PierronGTirodeFLucchesiC. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet2012;44:461–466.
Marino-EnriquezAFletcherCD. Round cell sarcomas: Biologically important refinements in subclassification. Int J Biochem Cell Biol2014;53:493–504.
94.
PetersTLKumarKPolikepehadS. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol2015;28:575–586.
95.
O'MearaEStackDPhelanS. Identification of an MLL4-GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child. Genes Chromosomes Cancer2014;53:991–998.
96.
SomersGRGuptaAADoriaAS. Pediatric undifferentiated sarcoma of the soft tissues: A clinicopathologic study. Pediatr Dev Pathol2006;9:132–142.
97.
YalomID. Love's Executioner and Other Tales of Psychotherapy. New York: Harper Perennial, 1989;171.
